JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 30, 2004; DOI: 10.1124/jpet.104.068692


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.068692v1
310/3/1020    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, F.
Right arrow Articles by Lawrence, A. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, F.
Right arrow Articles by Lawrence, A. J
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Antidepressants
Hazardous Substances DB
*DESIPRAMINE
*SERTRALINE


Received for publication March 22, 2004.
Revised April 27, 2004.
Accepted for publication April 28, 2004.

CHRONIC ANTIDEPRESSANT TREATMENT CAUSES A SELECTIVE REDUCTION OF µ-OPIOID RECEPTOR BINDING AND FUNCTIONAL COUPLING TO G-PROTEINS IN THE AMYGDALA OF FAWN-HOODED RATS

Feng Chen 1 Andrew J Lawrence 1*

1 Howard Florey Institute

* Address correspondence to: E-mail: andrew.lawrence{at}hfi.unimelb.edu.au

Abstract

We have previously documented that chronic alcohol consumption or alcohol withdrawal affects µ-opioid receptor density and receptor-mediated G-protein coupling in Fawn-Hooded rat brain, especially in mesolimbic regions (Chen and Lawrence, 2000; Djouma and Lawrence, 2002). Fawn-Hooded (FH) rats demonstrate co-morbid depression and high voluntary alcohol consumption; treatment with standard antidepressants improves both facets of this phenotype. Accordingly, we sought to examine whether µ-opioid receptor binding and the receptor-mediated functional coupling to G-protein is affected by this drug treatment. Using quantitative autoradiography, binding of µ-opioid receptors labelled by [125I]FK33,824 (D-Ala2, N-Me-Phe4-Met(O)-ol5-enkephalin) and the coupling between receptors and G-proteins determined by agonist-stimulated [35S]GTP{gamma}S ([35S]guanosine-5'-O-(3-thio)triphosphate) binding was mapped throughout brain sections of FH rats following 10 days treatment with vehicle, desipramine or sertraline. Both desipramine and sertraline produced significant decreases of [125I]FK33,824 binding in many brain regions; 13 out of 20 measured regions for desipramine, and 16 out of 20 measured regions for sertraline. The coupling efficiency of µ-opioid receptors to G-proteins was determined by an increase of [35S]GTP{gamma}S binding induced by stimulation with the µ-opioid receptor agonist DAMGO (D-Ala2, N-Me-Phe4-Gly-ol5-enkephalin; 10 µM). In contrast to the receptor binding profile, functional coupling of receptors to G-proteins was only significantly reduced in the amygdala while it remained unchanged in other regions compared to control. The present findings suggest that antidepressants regulate opioid systems, however, this occurs differentially and region-specific alteration of functional coupling of µ-opioid receptors to G proteins in the amygdala suggests that opioid function within the amygdala may be modulated by antidepressants.


Key words: amygdala, autoradiography, binding, depression, functional coupling, opioids





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.